Reported 16 days ago
Abbott Laboratories reported quarterly revenues of $11.37 billion, falling short of analysts' expectations of $11.40 billion, primarily due to a 6.6% decline in its diagnostics segment. Despite strong demand for medical devices, weak performance in diagnostics and nutrition resulted in nearly a 3% drop in shares. The company adjusted its annual profit outlook to a range between $5.12 and $5.18 per share.
Source: YAHOO